In the PD-1/PD-L1 pathway, binding of the PD-1 receptor on T cells to PD-L1 on antigen-presenting cells and tumor cells limits or halts the T cell response by downregulating cytokine production, effector function, and T cell proliferation. This evidence concerns the gene CD274 and neoplasm.